StreetAlpha.app
Home › Stocks › OMDA

Omada Health, Inc. (OMDA)

Healthcare
$11.87
▼ −5.04%
LAST CLOSE · NOV 20

Omada Health provides virtual chronic condition programs and physical therapy for employers, health plans, and other organizations that cover the cost. It last closed at $11.87 on Nov 20, down 5.04% on the day. The next earnings report for OMDA is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, OMDA reported EPS of $0.10 on revenue of $91.3M, with revenue up 34.2% from a year ago. Over its last 7 reports the stock moved an average of 9.8% the session after earnings. Over the last 12 months OMDA insiders bought $0 of stock on the open market and sold $12.2M, according to SEC Form 4 filings.

AI Auto Pilots
Is OMDA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold OMDA.

Key Stats

Last 12 months
Results
Revenue
$333.0M
+43.3% vs a year ago
Net income
$14.0M
4.2% margin
EPS (diluted)
$0.40
Free cash flow
$28.2M
8.5% margin
Valuation
Market cap
$736.4M
62.0M shares
P/E
29.7
Price over 12 month EPS
Price to sales
2.2
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$243.2M
At Sep 30
Shareholder equity
$273.2M
Shares outstanding
62.0M
At Nov 3
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2023: $122.8M$122.8MFY2023FY2024: $169.8M$169.8MFY2024FY2025: $260.2M$260.2MFY2025

From OMDA's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Next report
Jan 11
Estimated date · Time not announced
Reported EPS
$0.10
Quarter ended Sep 2026
Year ago EPS
-$0.06
Same quarter last year
Revenue
$91.3M
+34.2% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$1.02Dec '24Mar 2025: -$1.15Mar '25Jun 2025: -$0.24Jun '25Sep 2025: -$0.06Sep '25Dec 2025: $0.26Dec '25Mar 2026: -$0.05Mar '26Jun 2026: $0.08Jun '26Sep 2026: $0.10Sep '26Latest $0.10
Revenue by quarter
Dec 2024: $48.0MDec '24Mar 2025: $55.0MMar '25Jun 2025: $61.4MJun '25Sep 2025: $68.0MSep '25Dec 2025: $75.8MDec '25Mar 2026: $78.0MMar '26Jun 2026: $87.8MJun '26Sep 2026: $91.3MSep '26Latest $91.3M
How OMDA moved after its last 7 reports
Average move the session after a report ±9.8%
Nov 5, 2026After the close−20.4%
Aug 6, 2026After the close+21.1%
May 7, 2026After the close−9.6%
Mar 5, 2026After the close+3.3%
Jan 12, 2026Time not announced+4.6%
Nov 6, 2025After the close−7.1%
Aug 7, 2025After the close−2.3%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on OMDAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
Analyst calls from around the web
Last 90 days on OMDA: 0 upgrades, 0 downgrades, 0 initiations · Targets mentioned $25.00
JPMorgan Chase & CoTarget cut
Nov 16 $25.00

StreetAlpha's curated list of analyst calls collected from around the web. It may be incomplete or inaccurate, is not a consensus and is not advice.

AI Starter and AI Pro
Full analyst coverage on OMDA
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on OMDA

Technical Analysis

OMDA · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 37% below its 20 day and 56% below its 50 day average. It is 49% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 23), oversold. The nearest support is the Pivot S1 at $11.54, and the nearest resistance the Pivot at $12.09.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 9.0%/day
Key levels
$25.4552 week high+114.4%
$20.55100 day average+73.1%
$18.71Swing high (Jun 1)+57.6%
$18.4750 day average+55.6%
$17.70200 day average+49.1%
$16.3120 day average+37.4%
$12.42Pivot R1+4.6%
$12.09Pivot+1.9%
$11.87Last close
$11.54Pivot S1−2.8%
$10.2852 week low−13.4%
Indicators
RSI (14)22.56Oversold below 30Oversold
MACD-1.80Below its signal lineBearish
Stochastic1.0Near the bottom of its rangeOversold
ADX (14)36.9Trending down
Williams %R-98.7Oversold below −80, overbought above −20Oversold
CCI (20)-123.6Oversold below −100, overbought above 100Oversold
Rate of change−21.3%Change over 10 sessionsBearish
ATR (14)$1.07Typical daily range, 9.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for OMDA

What happened before

See how OMDA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Whale Options Flow

90D
Whale options flow for OMDAHow many large options trades hit OMDA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

OMDA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲144 buying vs 47 selling
  • ▲Held by funds +14.5 pts
  • ▲Funds holding +38
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding192154+24.7%
In funds' top 1036−50.0%
Held by funds99.3%84.8%+14.5 pts
New / increased57 / 8736 / 64+44.0%
Reduced / sold out28 / 1938 / 19−17.5%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See OMDA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

OMDA Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$12.2M38 sales · 4 insiders
65% of the selling was under pre-arranged trading plans.
2025-12 sold $298K2026-01 sold $4.2M2026-03 sold $85K2026-04 sold $36K2026-06 sold $2.5M2026-07 sold $1.9M2026-08 sold $1.5M2026-09 sold $1.1M2026-10 sold $357K2026-11 sold $249KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 4Sean P. DuffyCEOSale plan12,944$19.22$249K
Oct 1Sean P. DuffyCEOSale plan17,258$20.68$357K
Sep 10Wei-Li ShaoPresidentSale plan4,036$21.85$88K
Sep 10Steven L. CookCFOSale plan6,800$21.86$149K
Sep 10Sean P. DuffyCEOSale plan14,960$21.87$327K
Sep 9Craig GraceyChief Accounting OfficerSale plan644$21.73$14K
Every insider buy and sale for OMDA over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See OMDA insider trades →

From SEC Form 4 filings by OMDA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether OMDA is in one of them and how their past OMDA trades turned out.

OMDA in the AI portfolios
Loading…

OMDA News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered OMDA in an article yet. Here's the latest on the wider market.

OMDA in the news

About Omada Health

Omada Health is a virtual care company based in South San Francisco, California. Its programs help members manage chronic conditions such as prediabetes, diabetes, high blood pressure, and high cholesterol, and support weight loss, including for people taking GLP-1 medications. It also offers physical therapy for musculoskeletal conditions. Its customers include employers, health plans, health systems, and pharmacy benefit managers, which cover the cost of the programs for their members.

Headquarters
South San Francisco, CA